Advanced search    

Search: authors:"G. Viberti"

5 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes

, UKJ Karalliedde & G Viberti AuthorsSearch for J Karalliedde in:Nature Research journals • PubMed • Google ScholarSearch for G Viberti in:Nature Research journals • PubMed • Google Scholar Corresponding

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials

Health Care System and University of Washington , Seattle, WA, USA 2 ) ICM - Diabetes, The Medical School, Newcastle University , Framlington Place, Newcastle upon Tyne NE2 4HH, UK 3 G. Viberti Unit for

Sodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy.

The epidemiological evidence that only a subset of diabetic patients are susceptible to renal damage and the demonstration of clear familiar clustering of diabetic nephropathy are consistent with the possibility that genetic factors may explain the liability to or protection from renal disease of diabetic patients. A predisposition to hypertension and cardiovascular disease may...

Glycaemia, arterial pressure and micro-albuminuria in Type 1 (insulin-dependent) diabetes mellitus

Plasma glucose control and arterial pressure were assessed in 28 Type 1 (insulin-dependent) diabetic patients with different degrees of micro-albuminuria. They were divided into two groups according to their urinary albumin excretion rate: a low micro-albuminuria group (n= 16) with albumin excretion ranging between 12.1 and 28.9 μg/min and a high micro-albuminuria group (n= 12...